162 filings
15-12B
PBTH
PROLOR Biotech, Inc.
26 Sep 13
Securities registration termination
12:00am
EFFECT
PBTH
PROLOR Biotech, Inc.
9 Sep 13
Notice of effectiveness
12:00am
POS AM
PBTH
PROLOR Biotech, Inc.
6 Sep 13
Prospectus update (post-effective amendment)
12:00am
S-8 POS
PBTH
PROLOR Biotech, Inc.
6 Sep 13
Registration of securities for employees (post-effective amendment)
12:00am
S-8 POS
PBTH
PROLOR Biotech, Inc.
6 Sep 13
Registration of securities for employees (post-effective amendment)
12:00am
8-K
nrok5ps
30 Aug 13
Completion of Acquisition or Disposition of Assets
12:00am
25-NSE
pv7e7z
30 Aug 13
Exchange delisting
12:00am
DEFM14A
61uefy3a33 kq33uc
24 Jul 13
Proxy related to merger
12:00am
PRER14A
bz6muh2t
10 Jul 13
Preliminary revised proxy
12:00am
425
4g0oqb
3 Jul 13
Business combination disclosure
12:00am
8-K
ytdgimq5guu 7wlejqj
3 Jul 13
PROLOR BIOTECH TO PRESENT POSITIVE RESULTS FROM PRECLINICAL STUDIESOf
12:00am
PREM14A
uadcwc05qadjdivb66
28 Jun 13
Preliminary proxy related to merger
12:00am
8-K
h2n00bvf1 qua
17 Jun 13
Regulation FD Disclosure
12:00am
S-8
3734y47llbe09qf8
12 Jun 13
Registration of securities for employees
12:00am
8-K
xiw6gze2 pe9xoo
7 Jun 13
Departure of Directors or Certain Officers
12:00am
8-K
o1jag2zn0q
4 Jun 13
PROLOR BIOTECH initiates PIVOTAL phase III trial of ITS Longer-Acting Version of human growth hormone
12:00am
DEFA14A
1xuhzqmnd3 y86o09y8
4 Jun 13
Additional proxy soliciting materials
12:00am